Medicenna Therapeutics - 52 Year Dividend History | MDNAF
Historical dividend payout and yield for Medicenna Therapeutics (MDNAF) since 1971. The current TTM dividend payout for Medicenna Therapeutics (MDNAF) as of November 01, 2023 is $0.00. The current dividend yield for Medicenna Therapeutics as of November 01, 2023 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.097B |
$0.000B |
|
Medicenna Therapeutics Corp is a clinical stage immuno-oncology company. It is engaged in developing engineered versions of IL-2, IL4 and IL13 cytokines called Superkines and Empowered Cytokines ECs for the treatment of cancer. Medicenna Therapeutics Corp is based in Toronto, Canada.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
